Rational Development of Hypervalent Glycan Shield‐Binding Nanoparticles with Broad‐Spectrum Inhibition against Fatal Viruses Including SARS‐CoV‐2 Variants

Infectious virus diseases, particularly coronavirus disease 2019, have posed a severe threat to public health, whereas the developed therapeutic and prophylactic strategies are seriously challenged by viral evolution and mutation. Therefore, broad‐spectrum inhibitors of viruses are highly demanded....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Xu, Shuxin, Ye, Qing, Chi, Hang, Guo, Zhanchen, Chen, Jingran, Wu, Mei, Fan, Baochao, Li, Bin, Qin, Cheng‐Feng, Liu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839850/
https://www.ncbi.nlm.nih.gov/pubmed/36377484
http://dx.doi.org/10.1002/advs.202202689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839850/
https://www.ncbi.nlm.nih.gov/pubmed/36377484
http://dx.doi.org/10.1002/advs.202202689

Ejemplares similares